Skip to main content
Top
Published in: AIDS and Behavior 2/2017

Open Access 01-02-2017 | Original Paper

Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa

Authors: G. Abongomera, A. Cook, V. Musiime, C. Chabala, M. Lamorde, J. Abach, M. Thomason, V. Mulenga, A. Kekitiinwa, R. Colebunders, C. Kityo, A. S. Walker, D. M. Gibb

Published in: AIDS and Behavior | Issue 2/2017

Login to get access

Abstract

A high level of adherence to antiretroviral treatment is essential for optimal clinical outcomes in HIV infection, but measuring adherence is difficult. We investigated whether responses to a questionnaire eliciting caregiver beliefs in medicines were associated with adherence of their child (median age 2.8 years), and whether this in turn was associated with viral suppression. We used the validated beliefs in medicine questionnaire (BMQ) to measure caregiver beliefs, and medication event monitoring system caps to measure adherence. We found significant associations between BMQ scores and adherence, and between adherence and viral suppression. Among children initiating Antiretroviral therapy (ART), we also found significant associations between BMQ ‘necessity’ scores, and BMQ ‘necessity-concerns’ scores, and later viral suppression. This suggests that the BMQ may be a valuable tool when used alongside other adherence measures, and that it remains important to keep caregivers well informed about the long-term necessity of their child’s ART.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nyogea D, Mtenga S, Henning L, et al. Determinants of antiretroviral adherence among HIV positive children and teenagers in rural Tanzania: a mixed methods study. BMC Infect Dis. 2015;15:28.CrossRefPubMedPubMedCentral Nyogea D, Mtenga S, Henning L, et al. Determinants of antiretroviral adherence among HIV positive children and teenagers in rural Tanzania: a mixed methods study. BMC Infect Dis. 2015;15:28.CrossRefPubMedPubMedCentral
2.
go back to reference Skovdala M, Campbella C, Madanhireb C, Nyamukapab C, Gregson S. Challenges faced by elderly guardians in sustaining the adherence to antiretroviral therapy in HIV-infected children in Zimbabwe. AIDS Care. 2011;23(8):957–64.CrossRef Skovdala M, Campbella C, Madanhireb C, Nyamukapab C, Gregson S. Challenges faced by elderly guardians in sustaining the adherence to antiretroviral therapy in HIV-infected children in Zimbabwe. AIDS Care. 2011;23(8):957–64.CrossRef
3.
go back to reference Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.CrossRefPubMed Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.CrossRefPubMed
4.
go back to reference Coetzee B, Kagee A, Bland R. Barriers and facilitators to paediatric adherence to antiretroviral therapy in rural South Africa: a multi-stakeholder perspective. AIDS Care. 2015;27(3):315–21.CrossRefPubMed Coetzee B, Kagee A, Bland R. Barriers and facilitators to paediatric adherence to antiretroviral therapy in rural South Africa: a multi-stakeholder perspective. AIDS Care. 2015;27(3):315–21.CrossRefPubMed
5.
6.
go back to reference Senkomago V, Guwatudde D, Breda M, Khoshnood K. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda. AIDS Care. 2011;23(10):1246–53.CrossRefPubMed Senkomago V, Guwatudde D, Breda M, Khoshnood K. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda. AIDS Care. 2011;23(10):1246–53.CrossRefPubMed
7.
go back to reference Gusdal AK, Obua C, Andualem T, Wahlstrom R, Chalker J, Fochsen G. Peer counsellors’ role in supporting patients’ adherence to ART in Ethiopia and Uganda. AIDS Care. 2011;23(6):657–62.CrossRefPubMed Gusdal AK, Obua C, Andualem T, Wahlstrom R, Chalker J, Fochsen G. Peer counsellors’ role in supporting patients’ adherence to ART in Ethiopia and Uganda. AIDS Care. 2011;23(6):657–62.CrossRefPubMed
8.
go back to reference Kunutsor S, Walley J, Katabira E, et al. Improving clinic attendance and adherence to antiretroviral therapy through a treatment support intervention in Uganda: a randomized controlled Trial. AIDS Behav. 2011;15(3):1795–802.CrossRefPubMed Kunutsor S, Walley J, Katabira E, et al. Improving clinic attendance and adherence to antiretroviral therapy through a treatment support intervention in Uganda: a randomized controlled Trial. AIDS Behav. 2011;15(3):1795–802.CrossRefPubMed
9.
go back to reference Tusiime JB, Crane J, Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV + Ugandan parents and their children initiating HAART in the MTCT-plus family model: role of depression in declining adherence over time. AIDS Behav. 2009;13:S82–91.CrossRef Tusiime JB, Crane J, Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV + Ugandan parents and their children initiating HAART in the MTCT-plus family model: role of depression in declining adherence over time. AIDS Behav. 2009;13:S82–91.CrossRef
10.
go back to reference Gusdal AK, Obua C, Andualem T, et al. Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option? AIDS Care. 2009;21(11):1381–7.CrossRefPubMed Gusdal AK, Obua C, Andualem T, et al. Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option? AIDS Care. 2009;21(11):1381–7.CrossRefPubMed
11.
go back to reference Ware NC, Idoko J, Kaaya S, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6(1):e11.CrossRefPubMed Ware NC, Idoko J, Kaaya S, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6(1):e11.CrossRefPubMed
12.
go back to reference Mills EJ, Nachenga JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90.CrossRefPubMed Mills EJ, Nachenga JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90.CrossRefPubMed
13.
go back to reference Tusiime JB, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR. Adherence to HIV antiretroviral therapy in HIV + Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16:38–41.CrossRef Tusiime JB, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR. Adherence to HIV antiretroviral therapy in HIV + Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16:38–41.CrossRef
14.
go back to reference Haberer JE, Cook A, Walker AS, et al. Excellent adherence to antiretrovirals in HIV + Zambian children is compromised by disrupted routine, HIV non-disclosure, and paradoxical income effects. PLoS One. 2011;6(4):e18505.CrossRefPubMedPubMedCentral Haberer JE, Cook A, Walker AS, et al. Excellent adherence to antiretrovirals in HIV + Zambian children is compromised by disrupted routine, HIV non-disclosure, and paradoxical income effects. PLoS One. 2011;6(4):e18505.CrossRefPubMedPubMedCentral
15.
go back to reference Paterson DL, Potoski B, Capitano B. Measurement of adherence to antiretroviral medications. J Acq Immun Def Syndr. 2002;31:S103–6.CrossRef Paterson DL, Potoski B, Capitano B. Measurement of adherence to antiretroviral medications. J Acq Immun Def Syndr. 2002;31:S103–6.CrossRef
16.
go back to reference Petersen ML, Wang Y, van der Laan MJ, et al. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Inf Dis. 2007;45(7):908–15.CrossRef Petersen ML, Wang Y, van der Laan MJ, et al. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Inf Dis. 2007;45(7):908–15.CrossRef
17.
go back to reference Horne R, Cooper V, Gellairty G, Leake Date H, Fisher M. Patient’s perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity concerns framework. J Acquir Immune Defic Syndr. 2007;45:334–41.PubMed Horne R, Cooper V, Gellairty G, Leake Date H, Fisher M. Patient’s perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity concerns framework. J Acquir Immune Defic Syndr. 2007;45:334–41.PubMed
18.
go back to reference Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.CrossRefPubMedPubMedCentral Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.CrossRefPubMedPubMedCentral
19.
go back to reference Horne R. Weinman. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–67.CrossRefPubMed Horne R. Weinman. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–67.CrossRefPubMed
20.
go back to reference Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24.CrossRef Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24.CrossRef
21.
go back to reference Mulenga V, Musiime V, Kekitiinwa A, et al. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. Lancet Infect Dis. 2016;16(2):169–79.CrossRefPubMedPubMedCentral Mulenga V, Musiime V, Kekitiinwa A, et al. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. Lancet Infect Dis. 2016;16(2):169–79.CrossRefPubMedPubMedCentral
22.
go back to reference Gao X, Nau DP, Rosenbluth SA, et al. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000;12(4):387–98.CrossRefPubMed Gao X, Nau DP, Rosenbluth SA, et al. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000;12(4):387–98.CrossRefPubMed
23.
go back to reference Wanyama J, Castelnuovo B, Wandera B, et al. Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. AIDS. 2007;21(11):148.CrossRef Wanyama J, Castelnuovo B, Wandera B, et al. Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. AIDS. 2007;21(11):148.CrossRef
Metadata
Title
Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa
Authors
G. Abongomera
A. Cook
V. Musiime
C. Chabala
M. Lamorde
J. Abach
M. Thomason
V. Mulenga
A. Kekitiinwa
R. Colebunders
C. Kityo
A. S. Walker
D. M. Gibb
Publication date
01-02-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1582-8

Other articles of this Issue 2/2017

AIDS and Behavior 2/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.